Today's Updates

HIV Care Coordination Program May Reduce Deaths in NYC
Published Date: 15 Jun 2026

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Read More
Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes
Published Date: 15 Jun 2026

The drug was previously approved for stage 2 T1D.

Read More
One in Four Teen Girls and Young Women at Risk for PMOS
Published Date: 15 Jun 2026

Findings suggest young females should be assessed and, if at risk, monitored.

Read More
Palopegteriparatide Benefits Sustained Beyond 3 Years
Published Date: 15 Jun 2026

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Read More
Testosterone Prescribing Often Ignores Guidelines
Published Date: 15 Jun 2026

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Read More
Encaleret Shows Rapid Response in ADH1
Published Date: 15 Jun 2026

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Read More
Off-Label Rxs: Thinking Out of the Box for Skin Diseases
Published Date: 15 Jun 2026

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Read More
Urticaria Is Often a Team Sport for Derms and Allergists
Published Date: 15 Jun 2026

Chronic urticaria is occasionally challenging, but dermatologists and allergists can help each other as well as the patient by combining their unique skills in difficult cases.

Read More

Latest News

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

MHRA Isotretinoin Rules Wasted 12,000 Hours, Analysis Finds

Isotretinoin rules imposed over psychiatric concerns cost the NHS up to £1.4 million in wasted clinical time, dermatologists calculate.

Dr. Bolu Ogunyemi Becomes New CMA President

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.

Pictogram Decision Aid Tool Improves HCQ Adherence in Lupus

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

Can Oral Icotrokinra Relieve High-Impact Site Psoriasis?

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

Durable Benefit Seen With Personalized Melanoma Vaccine

For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.

Monthly Triple-Drug Combo Lowers Immune Reactions in Leprosy

Monthly rifampin-moxifloxacin-minocycline therapy lowers the risk for type 1 reactions in patients with Hansen disease, study shows.

Latest News

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

MHRA Isotretinoin Rules Wasted 12,000 Hours, Analysis Finds

Isotretinoin rules imposed over psychiatric concerns cost the NHS up to £1.4 million in wasted clinical time, dermatologists calculate.

Dr. Bolu Ogunyemi Becomes New CMA President

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.

Pictogram Decision Aid Tool Improves HCQ Adherence in Lupus

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

Can Oral Icotrokinra Relieve High-Impact Site Psoriasis?

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

Durable Benefit Seen With Personalized Melanoma Vaccine

For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.

Monthly Triple-Drug Combo Lowers Immune Reactions in Leprosy

Monthly rifampin-moxifloxacin-minocycline therapy lowers the risk for type 1 reactions in patients with Hansen disease, study shows.

News All Time

Abivax's Inflammatory Bowel Drug Meets Main Goal Of Late Stage Trial

Abivax said on Monday its experimental drug for patients with ulcerative colitis, a type of chronic inflammatory disease, met ⁠the main goal of a closely watched late-stage...

Sacroiliitis Worsening Commonly Found in Psoriatic Arthritis

A new study has uncovered factors associated with sacroiliitis progression in patients with psoriatic arthritis, as well as protective factors such as use of biologic and targeted DMARDs.

Birch Extract Boosts Wound Healing in EB: Long-Term Data

Oleogel-S10 accelerates wound healing and reduces wound burden in children with epidermolysis bullosa, a study finds.

US CDC Flags Health Risks Linked to Travel-related Cosmetic Procedures

The U.S. Centers for Disease Control and Prevention said on Tuesday that many Americans suffered serious complications — ⁠including bacterial infections and, in some cases,...

Camp Victory: Support, Connections for Kids With Vitiligo

A unique camp brings together children and youth with vitiligo and their parents to talk about their challenges. They don’t want to leave.

Doctor Helps Woman Stop Blaming Herself and Accept Treatment

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations.

IBS: New Dietetic Guidance Advises to ‘Think Beyond Diet’

Updated BDA guidance moves away from a diet-first approach to IBS, urging dietitians to consider lifestyle, mental health, and nondietary factors.

From K-pop to K-glow: Lasers, Face Firming Drive S Korea Tourism

Just over 2 million foreigners visited South Korea last year for medical treatment, nearly double the 2024 figure of ‌1.17 million.

Mohs for Rare Skin Cancer Linked to Lower Recurrence vs WLE

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

The Potential for Remission, Cure in Psoriasis

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

Genital Lesions Most Common Sign of CCD

Most patients with cutaneous Crohn’s disease present with genital lesions and show good response with biologic therapy, according to a study shows.

FDA Approves OTC Switch for Topical Acne Treatment

The product combining adapalene 0.1% and benzoyl peroxide 2.5% was approved as a prescription acne treatment in December 2008 for patients aged 12 years and older.

Botulinum Toxin for Frown Lines Moves Toward EU Approval

EMA advisers have backed a botulinum toxin for moderate to severe frown lines in adults, with reported onset of action as early as 8 hours and effects lasting 2-3 weeks.

Epidermolysis Bullosa: New Therapies Bring Hope, Healing

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.

Expert Guidance on Stacking Systemic Therapies for Psoriasis

Advice on when and how to switch or stack treatments can help in cases of an incomplete or waning response.

Endocrine Disruptors: Could Exposure Affect Generations?

Clinicians are urged to consider cumulative endocrine disruptor exposure in patients with unexplained hormonal and metabolic symptoms.

Recommended News For You

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Revolutionary Cancer Tx Could Transform Autoimmune Disease

In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.

Kate Middleton Announces Major Cancer Update

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

Low PSA May Not Fully Predict Survival in Prostate Cancer

Recommended Articles For You

Exploring the Normal Range of Monocytes: A Comprehensive Guide 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Essential Perspectives in Hematology and Patient Outcomes 

Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

3.

Could AI plus lasers help catch very early breast cancers?

4.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

5.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

1.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

2.

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver

3.

Unlocking the Mystery of Ovarian Cancer Staging

4.

Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025

5.

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

2.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Thromboprophylaxis In Medical Settings

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot